NCT03618628

Brief Summary

The purpose of this study is to determine the ability of carbon fiber off loading orthoses to reduce plantar pressure while providing an augmented plantarflexor power to improve walking and function. Results of this study could lead to increased use of carbon fiber off loading orthoses for patients with diabetes, peripheral neuropathy, and foot wounds as a way augmenting wound healing and preventing future recurrences of wounds.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Timeline
Completed

Started May 2016

Typical duration for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 24, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 12, 2018

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 16, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

August 7, 2018

Completed
9 months until next milestone

Results Posted

Study results publicly available

May 13, 2019

Completed
Last Updated

May 13, 2019

Status Verified

May 1, 2019

Enrollment Period

1.9 years

First QC Date

July 16, 2018

Results QC Date

September 17, 2018

Last Update Submit

May 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Peak Plantar Pressure

    Plantar pressure during walking while the participant wears the brace fabricated based on the finite element (FE) model compared to 1) the brace fabricated based on current clinical standards and 2) barefoot.

    Participant was tested in new brace (based on FE model) after wearing for 1 week.

Study Arms (1)

People using a CFO

EXPERIMENTAL

People who are currently wearing a carbon fiber off loading orthosis (CFO) will have a new CFO fabricated for them based on the results of our finite element (FE) model. We will then test both CFOs ability to reduce peak plantar compared to barefoot and the peak plantarflexor power of both braces.

Device: Carbon Fiber Off Loading Orthosis (CFO)

Interventions

A finite element (FE) model will be created to determine properties that will improve CFO strength while maintaining reduction of peak plantar pressures of the CFO and plantarflexor power. A new CFO will then be fabricated for the participant. Participants will be tested in while walking barefoot, wearing their current CFO, and wearing the FE model driven CFO.

People using a CFO

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Daily life includes a minimum of moderate activity level (variable cadence walking)
  • Have a Gillette or carbon off loading orthosis as a result of diabetes related foot impairments
  • Diagnosis of diabetes mellitus and peripheral neuropathy
  • Ability to ambulate in the community (K-level ≥ 2)
  • Age \> 21 years

You may not qualify if:

  • Unable to ambulate and complete testing required for study participation.
  • Severe foot deformity of the hindfoot or any deformity of the foot with a dislocation resulting in a bony prominence on the plantar/weightbearing surface of the foot.
  • Neurological diseases that affects walking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University

St Louis, Missouri, 63108, United States

Location

MeSH Terms

Conditions

Diabetes MellitusPeripheral Nervous System Diseases

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesNeuromuscular DiseasesNervous System Diseases

Results Point of Contact

Title
Dr. Mary Hastings
Organization
Washington University School of Medicine

Study Officials

  • Mary Hastings, DPT

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Physical Therapy, Orthopaedic Surgery

Study Record Dates

First Submitted

July 16, 2018

First Posted

August 7, 2018

Study Start

May 24, 2016

Primary Completion

April 12, 2018

Study Completion

April 12, 2018

Last Updated

May 13, 2019

Results First Posted

May 13, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations